Zaina Sangale

Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer

Melinda L. Telli, Kirsten M. Timms, Julia Reid et al. · Clinical Cancer Research · 2016 · 1.2K citations · Full text

Medicine, Genetics, Oncology +17

Association of BRCA1/2defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes

Kirsten M. Timms, Victor Abkevich, Elisha Hughes et al. · Breast Cancer Research · 2014 · 422 citations · Full text

Life Sciences, Genetics, Oncology +16

Prognostic Utility of the Cell Cycle Progression Score Generated from Biopsy in Men Treated with Prostatectomy

Jay T. Bishoff, Stephen J. Freedland, Leah Gerber et al. · The Journal of Urology · 2014 · 195 citations

Medicine, Oncology, Urology +17

Prognostic Utility of Cell Cycle Progression Score in Men With Prostate Cancer After Primary External Beam Radiation Therapy

Stephen J. Freedland, Leah Gerber, Julia Reid et al. · International Journal of Radiation Oncology*Biology*Physics · 2013 · 189 citations · Full text

Medicine, Oncology, Urology +17

Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated breast cancer

Melinda L. Telli, Jessica A. Hellyer, William Audeh et al. · Breast Cancer Research and Treatment · 2017 · 133 citations

Medicine, Genetics, Oncology +13